[1]
|
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin D.M., Forman, D. and Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. International Agency for Research on Cancer, yon, France. http://globocan.iarc.fr
|
[2]
|
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., et al. (2013) Cancer Incidence and Mortality Patterns in Europe: Estimates for 40 Countries in 2012. European Journal of Cancer, 49, 1374-1403. https://doi.org/10.1016/j.ejca.2012.12.027
|
[3]
|
(2014) Data Were Provided to Cancer Research UK by London School of Hygiene and Tropical Medicine on Request.
|
[4]
|
Wagner, M., Friess, H. and Buchler, W.M. (2015) Conservative versus Radical Resections of the Pancreas, Pancreatic Cancer: Molecular and Clinical Advances. Blackwell Science Ltd., Oxford.
|
[5]
|
Smeenk, H.G., Tran, T.C.K., Erdmann, J., van Eijck, C.H.J. and Jeekel, J. (2005) Survival after Surgical Management of Pancreatic Adenocarcinoma: Does Curative and Radical Surgery Truly Exist? Langenbeck’s Archives of Surgery, 390, 94-103.
https://doi.org/10.1007/s00423-004-0476-9
|
[6]
|
Kleeff, J., Reiser, C., Hinz, U., et al. (2007) Surgery for Recurrent Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 245, 566-572.
|
[7]
|
Morganti, A.G., Massaccesi, M., La Torre, G., et al. (2010) A Systematic Review of Resectability and Survival after Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer. Annals of Surgical Oncology, 17, 194-205.
https://doi.org/10.1245/s10434-009-0762-4
|
[8]
|
Shipley, W.U., Wood, W.C., Tepper, J.E., Warshaw, A.L., Orlow, E.L., Kaufman, S.D., et al. (1984) Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma. Annals of Surgery, 200, 289-296.
https://doi.org/10.1097/00000658-198409000-00006
|
[9]
|
Mohiuddin, M., Rosato, F., Barbot, D., Schuricht, A., Biermann, W. and Cantor, R. (1992) Long Term Results of Combined Modality Treatment with I-125 Implantation for Carcinoma of the Pancreas. International Journal of Radiation Oncology * Biology * Physics, 23, 305-311. https://doi.org/10.1016/0360-3016(92)90746-5
|
[10]
|
Bodner, R.W. and Hilaris, S.B. (1997) Brachytherapy and Pancreatic Cancer. Seminars in Surgical Oncology, 13, 204-207.
https://doi.org/10.1002/(SICI)1098-2388(199705/06)13:3<204::AID-SSU8>3.0.CO;2-B
|
[11]
|
Nori, D., Merimsky, O., Osian, A., Heffeman, M., Cortes, E. and Turner, J.W. (1996) Palladium-103: A New Radioactive Source in the Treatment of Unresectable Carcinoma of the Pancreas: A Phase I-II Study. Journal of Surgical Oncology, 61, 300-305.
https://doi.org/10.1002/(SICI)1096-9098(199604)61:4<300::AID-JSO14>3.0.CO;2-9
|
[12]
|
Wanebo, H.J., Glicksman, A.S., Vezerides, M.P., Clark, J., Tibbetts, L., Koness, R.J., et al. (2000) Preoperative Chemotherapy, Radiotherapy and Surgical Resection of Locally Advanced Pancreatic Cancer. Archives of Surgery, 135, 81-87.
https://doi.org/10.1001/archsurg.135.1.81
|
[13]
|
Mutignani, M., Shah, K.S., Morganti, A.G., Perri, V., Macchia, G. and Costamagna, G. (2002) Treatment of Unresectable Pancreatic Carcinoma by Intraluminal Brachytherapy in the Duct of Wirsung. Endoscopy, 34, 555-559. https://doi.org/10.1055/s-2002-33214
|
[14]
|
Mirza, A.N., Fornage, B.D., Sneige, N., Kuerer, H.M., Newman, L.A., Ames, F.C., et al. (2001) Radiofrequency Ablation of Solid Tumours. The Cancer Journal, 7, 95-102.
|
[15]
|
Salvatore, P., Roberto, S., Marco, R., Roberto, G., Isabella, F., Alessandro, G., Valentina, A. and Claudio, B. (2016) Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review. Gastroenterology Research and Practice, 2016, Article ID: 4508376. https://doi.org/10.1155/2016/4508376
|
[16]
|
Keane, M.G., Bramis, K., Pereira, S.P. and Fusai, G.K. (2014) Systematic Review of Novel Ablative Methods in Locally Advanced Pancreatic Cancer. World Journal of Gastroenterology, 20, 2267-2278. https://doi.org/10.3748/wjg.v20.i9.2267
|
[17]
|
Girelli, R., Frigerio, I., Giardino, A., et al. (2013) Results of 100 Pancreatic Radiofrequency Ablations in the Context of a Multimodal Strategy for Stage III Ductal Adenocarcinoma. Langenbeck’s Archives of Surgery, 398, 63-69. https://doi.org/10.1007/s00423-012-1011-z
|
[18]
|
Spiliotis, J.D., Datsis, A.C., Michalopoulos, N.V., et al. (2007) Radiofrequency Ablation Combined with Palliative Surgery May Prolong Survival of Patients with Advanced Cancer of the Pancreas. Langenbeck’s Archives of Surgery, 392, 55-60.
https://doi.org/10.1007/s00423-006-0098-5
|
[19]
|
Hadjicostas, P., Malakounides, N., Varianos, C., Kitiris, E., Lerni, F. and Symeonides, P. (2006) Radiofrequency Ablation in Pancreatic Cancer. HPB, 8, 61-64.
https://doi.org/10.1080/13651820500466673
|
[20]
|
Figueroa-Barojas, P., Bakhru, M.R., Habib, N.A., et al. (2013) Safety and Efficacy of Radiofrequency Ablation in the Management of Unresectable Bile Duct and Pancreatic Cancer: A Novel Palliation Technique. Journal of Oncology, 2013, Article ID: 910897.
|
[21]
|
Varshney, S., Sewkani, A., Sharma, S., et al. (2006) Radiofrequency Ablation of Unresectable Pancreatic Carcinoma: Feasibility, Efficacy and Safety. Journal of the Pancreas, 7, 74-78.
|
[22]
|
Wu, Y., Tang, Z., Fang, H., et al. (2006) High Operative Risk of Cool Tip Radiofrequency Ablation for Unresectable Pancreatic Head Cancer 1. Journal of Surgical Oncology, 94, 392-395. https://doi.org/10.1002/jso.20580
|
[23]
|
Matsui, Y., Nakagawa, A., Kamiyama, Y., Yamamoto, K., Kubo, N. and Nakase, Y. (2000) Selective Thermocoagulation of Unresectable Pancreatic Cancers by Using Radiofrequency Capacitive Heating. Pancreas, 20, 14-20.
https://doi.org/10.1097/00006676-200001000-00002
|
[24]
|
Date, R.S. and Siriwardena, A.K. (2005) Radiofrequency Ablation of the Pancreas. II: Intra-Operative Ablation of Non-Resectable Pancreatic Cancer. A Description of Technique and Initial Outcome. Journal of the Pancreas, 6, 588-592.
|
[25]
|
Chu, K.F. and Dupuy, D.E. (2014) Thermal Ablation of Tumours: Biological Mechanisms and Advances in Therapy. Nature Reviews Cancer, 14, 199-208.
https://doi.org/10.1038/nrc3672
|
[26]
|
Ali, M.Y., Grimm, C.F., Ritter, M., et al. (2005) Activation of Dendritic Cells by Local Ablation of Hepatocellular Carcinoma. Journal of Hepatology, 43, 817-822.
https://doi.org/10.1016/j.jhep.2005.04.016
|
[27]
|
Evrard, S., Menetrier-Caux, C., Biota, C., et al. (2007) Cytokines Pattern after Surgical Radiofrequency Ablation of Liver Colorectal Metastases. Gastroentérologie Clinique et Biologique, 31, 141-145. https://doi.org/10.1016/S0399-8320(07)89344-4
|
[28]
|
Fietta, A.M., Morosini, M., Passadore, I., et al. (2009) Systemic Inflammatory Response and Downmodulation of Peripheral CD25+Foxp3+T-Regulatory Cells in Patients Undergoing Radiofrequency Thermal Ablation for Lung Cancer. Human Immunology, 70, 477-486.
https://doi.org/10.1016/j.humimm.2009.03.012
|
[29]
|
Jansen, M.C., van Wanrooy, S., van Hillegersberg, R., et al. (2008) Assessment of Systemic Inflammatory Response (SIR) in Patients Undergoing Radiofrequency Ablation or Partial Liver Resection for Liver Tumours. European Journal of Surgical Oncology, 34, 662-667.
https://doi.org/10.1016/j.ejso.2007.06.009
|
[30]
|
Zerbini, A., Pilli, M., Laccabue, D., et al. (2010) Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response. Gastroenterology, 138, 1931-1942. https://doi.org/10.1053/j.gastro.2009.12.051
|
[31]
|
Hansler, J., Wissniowski, T.T., Schuppan, D., et al. (2006) Activation and Dramatically Increased Cytolytic Activity of Tumour Specific T Lymphocytes after Radio-Frequency Ablation in Patients with Hepatocellular Carcinoma and Colorectal Liver Metastases. World Journal of Gastroenterology, 12, 3716-3721.
|
[32]
|
Napoletano, C., Taurino, F., Biffoni, M., et al. (2008) RFA Strongly Modulates the Immune System and Anti-Tumour Immune Responses in Metastatic Liver Patients. International Journal of Oncology, 32, 481-490. https://doi.org/10.3892/ijo.32.2.481
|
[33]
|
Widenmeyer, M., Shebzukhov, Y., Haen, S.P., et al. (2011) Analysis of Tumour Antigen-Specific T Cells and Antibodies in Cancer Patients Treated with Radiofrequency Ablation. International Journal of Cancer, 128, 2653-2662. https://doi.org/10.1002/ijc.25601
|
[34]
|
Dromi, S.A., Walsh, M.P., Herby, S., et al. (2009) Radiofrequency Ablation Induces Antigen-Presenting Cell Infiltration and Amplification of Weak Tumour-Induced Immunity. Radiology, 251, 58-66. https://doi.org/10.1148/radiol.2511072175
|
[35]
|
Rovere-Querini, P. and Manfredi, A.A. (2004) Tumour Destruction and in Situ Delivery of Antigen Presenting Cells Promote Anti-Neoplastic Immune Responses: Implications for the Immunotherapy of Pancreatic cancer. Journal of the Pancreas, 5, 308-314.
|
[36]
|
Giardino, A., Girelli, R., Frigerio, I., et al. (2013) Triple Approach Strategy for Patients with Locally Advanced Pancreatic Carcinoma. HPB, 15, 623-627.
https://doi.org/10.1111/hpb.12027
|